Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluid therapy with or without furosemide in crush injury patients with lung contusion
IRCT20101220005426N14Phase 2Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of furosemide in Lung Contusion and Crush injury (2 arms), sponsored by Kerman University of Medical Sciences. Primary endpoints: Systolic blood pressure, Diastolic blood pressure and 11 more. Started Feb 2023; status: completed.
02
Drugs
furosemide
03
Conditions
Lung ContusionCrush injury
Beyond the preview
Go deeper on IRCT20101220005426N14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20101220005426N14.